temozolomide crinos
crinos s.p.a. - temozolomide - temozolomide
aloperidolo pensa
towa pharmaceutical s.p.a. - aloperidolo - aloperidolo
deferoxamina mesilato desfarma
desfarma srl - deferoxamina - deferoxamina
fobuler
orion corporation - formoterolo e budesonide - formoterolo e budesonide
pulmelia
elpen pharmaceutical co. inc. - formoterolo e budesonide - formoterolo e budesonide
temozolomide kabi
fresenius kabi italia s.r.l. - temozolomide - temozolomide
ossicodone molteni
l. molteni & c. dei f.lli alitti societa' di esercizio s.p.a. - ossicodone - ossicodone
bivalirudina accord
accord healthcare, s.l.u. - bivalirudina - bivalirudina
bivalirudina cipla
cipla europe nv - bivalirudina - bivalirudina
biresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - farmaci per le malattie respiratorie ostruttive, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).